Differential posttranscriptional regulation of androgen receptor gene expression by androgen in prostate and breast cancer cells

Endocrinology

Volumn 140, Issue 7, 1999, Pages 3282-3291

  Yeap, Bu B ^a   Krueger, Romano G ^b   Leedman, Peter J ^a,c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

^c Box X 2213 GPO   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANOLONE; MESSENGER RNA;

ARTICLE; BREAST CANCER; CANCER CELL; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETIC STABILITY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; REGULATORY MECHANISM; RNA METABOLISM; RNA TRANSCRIPTION;

EID: 0033305556     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.7.6769     Document Type: Article

References (56)

1. Prostate cancer: Emerging concepts
2. Cancer statistics, 1997
3. An adjustment to the 1997 estimate for new prostate cancer cases
4. Androgen signal transduction and prostatic carcinoma
5. Management of cancer of the prostate
6. How is androgen-dependent metastatic prostate cancer best treated?
7. Prostate cancer: Screening, diagnosis and management
8. Androgen receptor: An overview
9. Androgen-regulated gene expression in prostate cancer
10. Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer
11. Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence
12. Androgen receptor gene mutations in human prostate cancer
13. Androgens, antiandrogens and androgen receptor abnormalities
14. A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens
15. Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells
16. Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone
17. Mutated human androgen receptor gene detected in a prostatic cancer patient is also activated by estradiol
18. Prognostic factors in breast cancer
19. Clinical relevance of breast cancer biology
20. Androgen receptors in breast cancer
21. Medroxyprogesterone acetate therapy in advanced breast cancer: The predictive value of androgen receptor expression
22. Androgen receptors in operable breast cancer: Relation to other steroid hormone receptors, correlations to prognostic factors and predictive value for effect of adjuvant tamoxifen treatment
23. Medroxyprogesterone acetate inhibits the proliferation of estrogen- and progesterone-receptor negative MFM-223 human mammary cancer cells via the androgen receptor
24. Androgens induce divergent proliferative responses in human breast cancer cell lines
25. Dihydrotestosterone affects the growth of hormone-unresponsive breast cancer cells: An indirect action
26. Androgen receptor mediated growth control of breast cancer and endometrial cancer modulated by antiandrogen- and androgen-like steroids
27. Androgen-induced inhibition of proliferation in human breast cancer cells transfected with androgen receptor
28. The rat androgen receptor: Primary structure, autoregulation of its messenger ribonucleic acid, and immunocytochemical localization of the receptor protein
29. Autologous down-regulation of androgen receptor messenger ribonucleic acid
30. Androgen increases androgen receptor protein while decreasing receptor mRNA in LNCaP cells
31. Transcriptional and posttranscriptional regulation of human androgen receptor expression by androgen
32. Androgen receptor phosphorylation, turnover, nuclear transport and transcriptional activation: Specificity for steroids and antihormones
33. Specificity of ligand-dependent androgen receptor stabilization: Receptor domain interactions influence ligand dissociation and receptor stability
34. Regulation of androgen receptor gene expression by steroids and retinoic acid in human breast cancer cells
35. MDA-MB-453, an androgen-responsive human breast carcinoma cell line with high level androgen receptor expression
36. Characterization and expression of a cDNA encoding the human androgen receptor
37. The mRNA poly(A)-binding protein: Localization, abundance, and RNA-binding specificity
38. LNCaP model of human prostatic carcinoma
39. The androgen receptor: Functional structure and expression in transplanted human prostate tumors and prostate cell lines
40. Immortalized and tumorigenic adult human prostatic epithelial cell lines: Characteristics and applications. Part 2. Tumorigenic cell lines
41. Immortalized and tumorigenic adult human prostatic epithelial cell lines: Characteristics and applications part 1. Cell markers and immortalized nontumorigenic cell lines
42. Phosphotryptic peptide analysis of the human androgen receptor: Detection of a hormone-induced phosphopeptide
43. Androgen receptor phosphorylation
44. The down side of glucocorticoid receptor downregulation
45. Androgen and glucocorticoid regulation of androgen receptor cDNA expression
46. Transcriptional regulation of androgen receptor gene expression in Sertoli cells and other cell types
47. Regulation of the 5'-flanking region of the mouse androgen receptor gene by cAMP and androgen
48. Identification of 3',5'-cyclic adenosine monophosphate response element and other cis-acting elements in the human androgen receptor gene promoter
49. Second messenger up-regulation of androgen receptor gene transcription is absent in androgen insensitive human prostatic carcinoma cell lines PC-3 and DU-145
50. Transcriptional up-regulation of the human androgen receptor by androgen in bone cells
51. Autologous regulation of androgen receptor messenger ribonucleic acid in the separate lobes of the rat ventral prostate
52. Regulation of mRNA turnover in eukaryotic cells
53. Conserved structures and diversity of functions of RNA-binding proteins
54. Cytoplasmic mRNA-protein interactions in eukaryotic gene expression
55. AU-rich elements: Characterization and importance in mRNA degradation
56. Suppression of malignancy by the 3' untranslated regions of ribonucleotide reductase R1 and R2 messenger RNAs